127 related articles for article (PubMed ID: 1660312)
1. Idiotypic analysis of human anti-topoisomerase I autoantibodies.
Hildebrandt S; Noell GS; Vazquez-Abad D; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 10(1):41-8. PubMed ID: 1660312
[TBL] [Abstract][Full Text] [Related]
2. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in systemic sclerosis.
Vázquez-Abad D; Rothfield NF
Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
[TBL] [Abstract][Full Text] [Related]
4. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.
Verheijen R; de Jong BA; van Venrooij WJ
Clin Exp Immunol; 1992 Sep; 89(3):456-60. PubMed ID: 1325307
[TBL] [Abstract][Full Text] [Related]
5. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
[TBL] [Abstract][Full Text] [Related]
6. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
Weiner ES; Earnshaw WC; Senécal JL; Bordwell B; Johnson P; Rothfield NF
Arthritis Rheum; 1988 Mar; 31(3):378-85. PubMed ID: 2833902
[TBL] [Abstract][Full Text] [Related]
7. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
8. Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase I autoantibodies.
Muryoi T; Kasturi KN; Kafina MJ; Saitoh Y; Usuba O; Perlish JS; Fleischmajer R; Bona CA
Autoimmunity; 1991; 9(2):109-17. PubMed ID: 1718459
[TBL] [Abstract][Full Text] [Related]
9. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
[TBL] [Abstract][Full Text] [Related]
10. The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.
Hildebrandt S; Weiner E; Senécal JL; Noell S; Daniels L; Earnshaw WC; Rothfield NF
Arthritis Rheum; 1990 May; 33(5):724-7. PubMed ID: 2161233
[TBL] [Abstract][Full Text] [Related]
11. CRI-EM is a human idiotype highly specific for scleroderma.
Vázquez-Abad D; Tian L; Monteón V; Zanetti M; Rothfield NF
Ann N Y Acad Sci; 1997 Apr; 815():512-5. PubMed ID: 9186713
[No Abstract] [Full Text] [Related]
12. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
[TBL] [Abstract][Full Text] [Related]
13. A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies.
Hildebrandt S; Jäckh G; Weber S; Peter HH
Rheumatol Int; 1993; 12(6):231-4. PubMed ID: 8387225
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human antitopoisomerase-I idiotypes.
Vazquez-Abad D; Pascual V; Zanetti M; Rothfield NF
J Clin Invest; 1993 Sep; 92(3):1302-13. PubMed ID: 8397223
[TBL] [Abstract][Full Text] [Related]
15. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
17. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
18. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.
Martínez-Cordero E; Trejo AP; León DE
J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342
[TBL] [Abstract][Full Text] [Related]
19. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
20. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y
Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
